191 related articles for article (PubMed ID: 36840409)
1. Sclerostin blockade promotes bone metastases of Wnt-responsive breast cancer cells.
Hiraga T; Horibe K; Koide M; Yamashita T; Kobayashi Y
Cancer Sci; 2023 Jun; 114(6):2460-2470. PubMed ID: 36840409
[TBL] [Abstract][Full Text] [Related]
2. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
[TBL] [Abstract][Full Text] [Related]
3. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.
Mendoza-Villanueva D; Zeef L; Shore P
Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690
[TBL] [Abstract][Full Text] [Related]
4. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
5. WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth.
Matsuda Y; Schlange T; Oakeley EJ; Boulay A; Hynes NE
Breast Cancer Res; 2009; 11(3):R32. PubMed ID: 19473496
[TBL] [Abstract][Full Text] [Related]
6. Ganoderma lucidum (Reishi) suppresses proliferation and migration of breast cancer cells via inhibiting Wnt/β-catenin signaling.
Zhang Y
Biochem Biophys Res Commun; 2017 Jul; 488(4):679-684. PubMed ID: 28427938
[TBL] [Abstract][Full Text] [Related]
7. Wnt/β-catenin pathway regulates bone morphogenetic protein (BMP2)-mediated differentiation of dental follicle cells.
Silvério KG; Davidson KC; James RG; Adams AM; Foster BL; Nociti FH; Somerman MJ; Moon RT
J Periodontal Res; 2012 Jun; 47(3):309-19. PubMed ID: 22150562
[TBL] [Abstract][Full Text] [Related]
8. Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness.
Hesse E; Schröder S; Brandt D; Pamperin J; Saito H; Taipaleenmäki H
JCI Insight; 2019 Apr; 5(9):. PubMed ID: 30965315
[TBL] [Abstract][Full Text] [Related]
9. Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells.
Taipaleenmäki H; Farina NH; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
Oncotarget; 2016 Nov; 7(48):79032-79046. PubMed ID: 27738322
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastases.
Bu G; Lu W; Liu CC; Selander K; Yoneda T; Hall C; Keller ET; Li Y
Int J Cancer; 2008 Sep; 123(5):1034-42. PubMed ID: 18546262
[TBL] [Abstract][Full Text] [Related]
11. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
12. Sclerostin Antibody Administration Increases the Numbers of Sox9creER+ Skeletal Precursors and Their Progeny.
Balani DH; Trinh S; Xu M; Kronenberg HM
J Bone Miner Res; 2021 Apr; 36(4):757-767. PubMed ID: 33400836
[TBL] [Abstract][Full Text] [Related]
13. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
14. β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis.
Klemm F; Bleckmann A; Siam L; Chuang HN; Rietkötter E; Behme D; Schulz M; Schaffrinski M; Schindler S; Trümper L; Kramer F; Beissbarth T; Stadelmann C; Binder C; Pukrop T
Carcinogenesis; 2011 Mar; 32(3):434-42. PubMed ID: 21173432
[TBL] [Abstract][Full Text] [Related]
15. Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders.
Marini F; Giusti F; Palmini G; Brandi ML
Osteoporos Int; 2023 Feb; 34(2):213-238. PubMed ID: 35982318
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
[TBL] [Abstract][Full Text] [Related]
17. γ-Tocotrienol reversal of epithelial-to-mesenchymal transition in human breast cancer cells is associated with inhibition of canonical Wnt signalling.
Ahmed RA; Alawin OA; Sylvester PW
Cell Prolif; 2016 Aug; 49(4):460-70. PubMed ID: 27323693
[TBL] [Abstract][Full Text] [Related]
18. Loss of sclerostin promotes osteoarthritis in mice via β-catenin-dependent and -independent Wnt pathways.
Bouaziz W; Funck-Brentano T; Lin H; Marty C; Ea HK; Hay E; Cohen-Solal M
Arthritis Res Ther; 2015 Feb; 17(1):24. PubMed ID: 25656376
[TBL] [Abstract][Full Text] [Related]
19. Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway.
Tao K; Xiao D; Weng J; Xiong A; Kang B; Zeng H
Toxicol Lett; 2016 Jan; 240(1):68-80. PubMed ID: 26478571
[TBL] [Abstract][Full Text] [Related]
20. Wnt/β-Catenin Signaling Pathway Regulates Osteogenesis for Breast Cancer Bone Metastasis: Experiments in an
Kar S; Jasuja H; Katti DR; Katti KS
ACS Biomater Sci Eng; 2020 May; 6(5):2600-2611. PubMed ID: 33463270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]